Dissemination in distinct Brazilian regions of an epidemic carbapenem-resistant Pseudomonas aeruginosa producing SPM metallo-β-lactamase

Journal of Antimicrobial Chemotherapy

Volumn 52, Issue 4, 2003, Pages 699-702

  Gales, Ana C ^a   Menezes, Liana C ^a   Silbert, Suzane ^a   Sader, Hélio S ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Brazil; Carbapenem resistance; Gram negative bacilli

Indexed keywords

BETA LACTAMASE; CARBAPENEM; COLISTIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BRAZIL; CONTROLLED STUDY; GENETIC CODE; GEOGRAPHIC DISTRIBUTION; HOSPITAL; IN VITRO STUDY; NONHUMAN; POLYMERASE CHAIN REACTION; PSEUDOMONAS AERUGINOSA; PULSED FIELD GEL ELECTROPHORESIS; RIBOTYPING; SCREENING TEST;

BETA-LACTAM RESISTANCE; BETA-LACTAMASES; BRAZIL; CARBAPENEMS; DISEASE OUTBREAKS; HUMANS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 0141997696     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkg416     Document Type: Article

References (10)

1. Sader, H. S., Gales, A. C., Pfaller, M. A. et al. (2001). Pathogen frequency and resistance patterns in Brazilian hospitals: summary of results from three years of the SENTRY Antimicrobial Surveillance Program. Brazilian Journal of Infectious Disease 5, 200-14.
2. Richards, M. J., Edwards, J. R., Culver, D. H. et al. (1999). Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Critical Care Medicine 27, 887-92.
3. Livermore, D. M. (2002). Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? Clinical Infectious Diseases 34, 634-40.
4. Gales, A. C., Jones, R. N., Turnidge, J. et al. (2001). Characterization of Pseudomonas aeruginosa isolates: occurrence rates, antimicrobial susceptibility patterns, and molecular typing in the global SENTRY Antimicrobial Surveillance Program, 1997-1999. Clinical Infectious Diseases 32, Suppl. 2, 146-55.
5. Nordmann, P. & Poirel, L. (2002). Emerging carbapenemases in Gram-negative aerobes. Clinical Microbiology and Infection 8, 321-31.
6. Pellegrino, F. L., Teixeira, L. M., Carvalho Md, M. G. et al. (2002). Occurrence of a multidrug-resistant Pseudomonas aeruginosa clone in different hospitals in Rio de Janeiro, Brazil. Journal of Clinical Microbiology 40, 2420-4.
7. Toleman, M. A., Simm, A. M., Murphy, T. A. et al. (2002). Molecular characterization of SPM-1, a novel metallo-beta-lactamase isolated in Latin America: report from the SENTRY antimicrobial surveillance programme. Journal of Antimicrobial Chemotherapy 50, 673-9.
8. National Committee for Clinical Laboratory Standards. (2002). Performance Standards for Antimicrobial Susceptibility Testing - Twelfth Informational Supplement M100-S12. NCCLS, Wayne, PA, USA.
9. Arakawa, Y., Shibata, N., Shibayama, K. et al. (2000). Convenient test for screening metallo-beta-lactamase-producing gram-negative bacteria by using thiol compounds. Journal of Clinical Microbiology 38, 40-3.
10. Bertrand, X., Thouverez, M., Talon, D. et al. (2001). Endemicity, molecular diversity and colonisation routes of Pseudomonas aeruginosa in intensive care units. Intensive Care Medicine 27, 1263-8.